Showing results (61-70 of 356) with videos related to

Sort By:
Pageof 36
Hepatology (Baltimore, Md.)|April 2, 2004
Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4Ursula Ehmer, Arndt Vogel, Jan Karl Schütte, et al.
Scandinavian Journal of Gastroenterology|May 25, 2019
Endoscopic biliary drainage in patients with cholangiocarcinoma - self-expanding metal versus polyethylene stentsTorsten Voigtländer, Nora Schweitzer, Thomas von Hahn, et al.
Molecular Immunology|February 7, 2009
High initial frequency of TCR-transgenic CD8 T cells alters inflammation and pathogen clearance without affecting memory T cell functionThomas C Wirth, Nhat-Long L Pham, John T Harty, et al.
Therapeutic Advances in Medical Oncology|September 2, 2022
Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver functionJasmine Huynh, May Thet Cho, Edward Jae-Hoon Kim, et al.
The American Journal of Pathology|August 8, 2009
The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasisPadmavathi devi Nalapareddy, Sven Schüngel, Ji-Young Hong, et al.
Hepatology (Baltimore, Md.)|July 17, 2015
Prediction of short- and long-term outcome in patients with autoimmune hepatitisMartha M Kirstein, Frauke Metzler, Elena Geiger, et al.
Zeitschrift Fur Gastroenterologie|June 6, 2020
[Best supportive care in a young patient with locally advanced MSI-high colon cancer?]Sabrina Welland, Tiago De Castro, Thomas Wirth, et al.
Cancers|July 2, 2021
Next-Generation Biomarkers for CholangiocarcinomaPedro M Rodrigues, Arndt Vogel, Marco Arrese, et al.
Liver Cancer|April 13, 2026
Impact of Age on Patient-Reported Outcomes with First-Line Camrelizumab plus Rivoceranib versus Sorafenib in Adults with Unresectable Hepatocellular Carcinoma: Post Hoc Analyses of the CARES-310 Open-Label, Randomized, Phase 3 TrialStephen Lam Chan, Ahmed Omar Kaseb, Laura Alexander, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Differentiation of central memory CD8 T cells is independent of CD62L-mediated trafficking to lymph nodesThomas C Wirth, Vladimir P Badovinac, Lichao Zhao, et al.
Pageof 36